Indolent Non-Hodgkin Lymphoma
Showing 1 - 22 of 22
Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)
Not yet recruiting
- Follicular Lymphoma
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 13, 2023
R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial (CNTY-101, IL-2,
Recruiting
- R/R CD19-Positive B-Cell Malignancies
- +2 more
- CNTY-101
- +2 more
-
Detroit, Michigan
- +1 more
Dec 21, 2022
Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
-
Shanghai, ChinaRuijin hospital, school of medicine, Shanghai jiao tong universi
Oct 3, 2022
Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +13 more
- Cyclophosphamide
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 18, 2022
Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +9 more
- Cryosurgery
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 9, 2022
Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,
Recruiting
- Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
- +13 more
- Cyclophosphamide
- +6 more
-
Scottsdale, Arizona
- +2 more
Jun 1, 2022
Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)
Recruiting
- Chronic Lymphocytic Leukemia
- +6 more
- Copanlisib
- Nivolumab
-
Duarte, California
- +2 more
Mar 9, 2022
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,
Recruiting
- Grade 1 Follicular Lymphoma
- +7 more
- Acalabrutinib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 7, 2021
Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,
Recruiting
- Mantle Cell Lymphoma
- +5 more
- CAR.k.28
- +3 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021
Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Locally Advanced Malignant Solid Tumor Trial run by the NCI (p97
Withdrawn
- Aggressive Non-Hodgkin Lymphoma
- +3 more
- p97 Inhibitor CB-5339 Tosylate
-
Bethesda, Maryland
- +1 more
Aug 27, 2021
Indolent Non-hodgkin Lymphoma Trial in München (Obinutuzumab, Bendamustine)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
-
München, Bavaria, GermanyKlinikum der Universität München
Jul 23, 2021
Indolent Non-hodgkin Lymphoma Trial in Worldwide (Duvelisib)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
-
Washington, District of Columbia
- +39 more
May 17, 2021
Indolent Non-Hodgkin Lymphoma Trial in München (Ibrutinib, GA 101)
Active, not recruiting
- Indolent Non-Hodgkin Lymphoma
- Ibrutinib
- GA 101
-
München, Bavaria, GermanyKlinikum der Universität München
May 6, 2021
Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Aichi, Miyagi, Tokyo (Idelalisib)
Completed
- Chronic Lymphocytic Leukemia
- +5 more
-
Aichi, Japan
- +2 more
Feb 24, 2021
Indolent Non-Hodgkin Lymphoma Trial in Worldwide (Duvelisib)
Active, not recruiting
- Indolent Non-Hodgkin Lymphoma
-
Los Angeles, California
- +68 more
Mar 15, 2021
Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor
Recruiting
- Non-Hodgkin's Lymphoma
- +18 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021
Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)
Terminated
- Burkitt Lymphoma
- +6 more
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 30, 2020
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in United States (procedure, drug,
Completed
- Acute Lymphoblastic Leukemia
- +25 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Aurora, Colorado
- +5 more
Dec 17, 2019
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States
Completed
- Acute Lymphoblastic Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Denver, Colorado
- +10 more
Oct 10, 2019